Your browser doesn't support javascript.
loading
Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression.
Shi, Ziyan; Wang, Xiaofei; Wang, Jiancheng; Chen, Hongxi; Du, Qin; Lang, Yanlin; Kong, Lingyao; Luo, Wenqin; Qiu, Yuhan; Zhang, Ying; Li, Chen; Wen, Dingke; Yao, Jie; Cheng, Xia; Cai, Linjun; Lin, Xue; Wang, Rui; Mou, Zichao; Li, Shuangjie; Liu, Duanya; Zhou, Hong; Zhou, Hongyu; Yang, Mu.
Affiliation
  • Shi Z; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Wang X; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Wang J; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Chen H; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Du Q; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Lang Y; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Kong L; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Luo W; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Qiu Y; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Zhang Y; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Li C; Centre for Translational Research in Cancer, Sichuan Cancer Hospital and Institute, No.55 South Renmin Road, Chengdu, 610000, China.
  • Wen D; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610000, China.
  • Yao J; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Cheng X; Centre for Translational Research in Cancer, Sichuan Cancer Hospital and Institute, No.55 South Renmin Road, Chengdu, 610000, China.
  • Cai L; Centre for Translational Research in Cancer, Sichuan Cancer Hospital and Institute, No.55 South Renmin Road, Chengdu, 610000, China.
  • Lin X; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Wang R; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Mou Z; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Li S; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Liu D; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China.
  • Zhou H; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610000, China.
  • Zhou H; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610000, China.
  • Yang M; Department of Neurology, West China Hospital, Sichuan University, No.28 Dianxin Nan Street, Chengdu, 610041, China. zhouhy@scu.edu.cn.
J Neuroinflammation ; 20(1): 138, 2023 Jun 02.
Article de En | MEDLINE | ID: mdl-37268957

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sclérose en plaques chronique progressive / Sclérose en plaques récurrente-rémittente / Sclérose en plaques Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: J Neuroinflammation Sujet du journal: NEUROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sclérose en plaques chronique progressive / Sclérose en plaques récurrente-rémittente / Sclérose en plaques Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: J Neuroinflammation Sujet du journal: NEUROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni